HomeEJXB • FRA
add
Elekta AB (publ)
Previous close
€5.37
Day range
€5.13 - €5.28
Year range
€5.10 - €7.57
Market cap
22.28B SEK
Avg Volume
67.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | 4.34B | -8.26% |
Operating expense | 1.17B | 4.76% |
Net income | 212.00M | -38.37% |
Net profit margin | 4.88 | -32.87% |
Earnings per share | 0.63 | — |
EBITDA | 533.00M | -27.58% |
Effective tax rate | 22.10% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.35B | 79.35% |
Total assets | 32.54B | 2.91% |
Total liabilities | 22.07B | 3.86% |
Total equity | 10.47B | — |
Shares outstanding | 382.08M | — |
Price to book | 0.20 | — |
Return on assets | 2.95% | — |
Return on capital | 4.93% | — |
Cash Flow
Net change in cash
| (SEK) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | 212.00M | -38.37% |
Cash from operations | 456.00M | -26.81% |
Cash from investing | -574.00M | 6.97% |
Cash from financing | 1.05B | 293.35% |
Net change in cash | 988.00M | 298.39% |
Free cash flow | 37.00M | -80.82% |
About
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees. Wikipedia
Founded
1972
Website
Employees
4,580
